AI Drug Discovery for Parkinson’s Disease: Why This $66 Million Deal Matters
AI drug discovery for Parkinson’s disease is no longer theoretical. A $66 million deal to develop an AI-designed, brain-penetrant drug targeting neuroinflammation shows how artificial intelligence …